Form D · Biotechnology
Cupron Performance Additives, Inc.
Richmond, VA · CIK 0002054678
Offering snapshot reported Feb 3, 2025 · SEC filing
- Reported sold
- $4.4M Offering amount: $7.5M
- Investors reported
- 12 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jan 10, 2025 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Feb 3, 2025 | Initial | $4,400,000 | No comparison | 12 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-537108
Source: Form D, filed Feb 3, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Christopher Andrews | Director, Executive |
| James Read Branch | Director |
| Michael Britt | Executive |
| Francis Claiborne Johnston | Director |
| Louis William Moelchert | Director |
| Thomas Justin Moore | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
4329 November Avenue
Richmond, VA, 23231
Richmond, VA, 23231